Alihodzic, D.; Wicha, S.G.; Frey, O.R.; König, C.; Baehr, M.; Jarczak, D.; Kluge, S.; Langebrake, C.
Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study. Pharmaceutics 2022, 14, 965.
https://doi.org/10.3390/pharmaceutics14050965
AMA Style
Alihodzic D, Wicha SG, Frey OR, König C, Baehr M, Jarczak D, Kluge S, Langebrake C.
Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study. Pharmaceutics. 2022; 14(5):965.
https://doi.org/10.3390/pharmaceutics14050965
Chicago/Turabian Style
Alihodzic, Dzenefa, Sebastian G. Wicha, Otto R. Frey, Christina König, Michael Baehr, Dominik Jarczak, Stefan Kluge, and Claudia Langebrake.
2022. "Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study" Pharmaceutics 14, no. 5: 965.
https://doi.org/10.3390/pharmaceutics14050965
APA Style
Alihodzic, D., Wicha, S. G., Frey, O. R., König, C., Baehr, M., Jarczak, D., Kluge, S., & Langebrake, C.
(2022). Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study. Pharmaceutics, 14(5), 965.
https://doi.org/10.3390/pharmaceutics14050965
